Annals On Call - Do Cannabinoids Help Chronic Pain?
Authors: Robert M. Centor, Devan Kansagara
Journal: Annals of Internal Medicine (2022)

Web ExclusivesSeptember 2022Annals On Call - Do Cannabinoids Help Chronic Pain?FREERobert M. Centor, MD and Devan Kansagara, MD, MCRRobert M. Centor, MDHuntsville Regional Medical Campus, University of Alabama Birmingham School of Medicine, Birmingham, Alabama (R.M.C.)Search for more papers by this author and Devan Kansagara, MD, MCRPortland VA Health Care System, Evidence-based Synthesis Program, Portland, Oregon (D.K.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/A21-0018 CME/MOC SectionsAboutVisual Abstract ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In this episode of Annals On Call, Dr. Centor discusses the use of cannabis products to treat chronic pain with Dr. Devan Kansagara.Annals articles discussed include...Cannabis-Based Products for Chronic Pain. A Systematic Review: https://www.acpjournals.org/doi/10.7326/M21-4520About Annals On CallAnnals On Call focuses on a clinically influential article published in Annals of Internal Medicine. Dr. Robert Centor shares his own perspective on the material and interviews topic area experts to discuss, debate, and share diverse insights about patient care and health care delivery.For more information on Annals On Call and for more episodes, visit go.annals.org/OnCall. Comments0 CommentsSign In to Submit A Comment Author, Article, and Disclosure InformationAffiliations: Huntsville Regional Medical Campus, University of Alabama Birmingham School of Medicine, Birmingham, Alabama (R.M.C.)Portland VA Health Care System, Evidence-based Synthesis Program, Portland, Oregon (D.K.)Disclosures: All relevant financial relationships have been mitigated. Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=A21-0018.Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Stephanie Chang, MD, MPH, Deputy Editor, reports employment with the Agency for Healthcare Research and Quality, travel compensation from the Guidelines International Network, and participation in the Patient-Centered Outcomes Research Institute methodology committee. Vineet Chopra, MD, MSc, Deputy Editor, reports grants received from the Agency for Healthcare Research and Quality and royalties from UpToDate and Oxford University Press. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interests to disclose. Eliseo Guallar, MD, MPH, DrPH, Deputy Editor, Statistics, reports that he is employed at Johns Hopkins University. Christina C. Wee, MD, MPH, Deputy Editor, reports employment with Beth Israel Deaconess Medical Center and consultancy with Boston Medical Center. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Yu-Xiao Yang, MD, MSCE, Deputy Editor, reports employment with the Perelman School of Medicine, University of Pennsylvania, and consultancies with the U.S. Food and Drug Administration and the State of Colorado.This article was published at Annals.org on 6 September 2022. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoCannabis-Based Products for Chronic Pain Marian S. McDonagh , Benjamin J. Morasco , Jesse Wagner , Azrah Y. Ahmed , Rongwei Fu , Devan Kansagara , and Roger Chou Metrics September 2022Volume 175, Issue 9Page: OC1 ePublished: 6 September 2022 Issue Published: September 2022 Copyright & PermissionsCopyright © 2022 by American College of Physicians. All Rights Reserved.Loading ...